ConductScience.org, home

Paper761001

Metabolic consequences of atenolol and propranolol in treatment of essential hypertension.

Day JL and 3 others. Br Med J, 1979. Cited by 220 papers, by iCite.

Cite this record

ConductScience Library. Metabolic consequences of atenolol and propranolol in treatment of essential hypertension. Papers, record 761001. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/761001

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Metabolic consequences of atenolol and propranolol in treatment of essential hypertension.
PubMed
Journal
Br Med J
PubMed
Year
1979
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
220
iCite
Relative citation ratio, by iCite
12.5
iCite
Revised in PubMed
2019-05-01
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Day JLJ L
2Simpson NN
3Metcalfe JJ
4Page RLR L

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AtenololMajor topic
HypertensionMajor topic
PropanolaminesMajor topic
PropranololMajor topic
Adult
Blood Glucose
Cholesterol
Fatty Acids, Nonesterified
Glucagon
Growth Hormone
Humans
Insulin
Male
Middle Aged
Triglycerides

Source PubMed

Download CSV of topics

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1984073Elevation of serum lipid levels during diuretic therapy of hypertension.Am J Med1976https://conductscience.org/library/papers/984073PubMed
217448Beta-blockers and lipid metabolism.Br Med J1977https://conductscience.org/library/papers/17448PubMed
3184363Effect of chronic administration of propranolol on lipoprotein composition.Metabolism1976https://conductscience.org/library/papers/184363PubMed
44696745Propranolol and hypertriglyceridemia.Atherosclerosis1973https://conductscience.org/library/papers/4696745PubMed
54125216[Effect of beta sympatholytic agent ICI 50172 (Dalzic) in various cardiovascular diseases].Med Klin1973https://conductscience.org/library/papers/4125216PubMed
64399102The effect of beta-adrenergic blocking agents on serum lipids.Atherosclerosis1971https://conductscience.org/library/papers/4399102PubMed
74379758On sympathetic regulation of carbohydrate metabolism in the liver.J Pharm Pharmacol1965https://conductscience.org/library/papers/4379758PubMed
846384Effects of long-term practolol therapy on plasma-lipids after acute myocardial infarction.Lancet1975https://conductscience.org/library/papers/46384PubMed
9238094The metabolic consequences of adrenergic blockade: a reveiw.Metabolism1975https://conductscience.org/library/papers/238094PubMed
105429278The effect of physical training on insulin production in obesity.Metabolism1970https://conductscience.org/library/papers/5429278PubMed

Download CSV of references

Cited by40

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 220 citations.

PMIDTitleJournalYearIn PapersSource
23536766Pharmacometabolomics reveals racial differences in response to atenolol treatment.PLoS One2013https://conductscience.org/library/papers/23536766PubMed
20795842Atenolol exposure and risk for development of adverse metabolic effects: a pilot study.Pharmacotherapy2010https://conductscience.org/library/papers/20795842PubMed
7433322Beta-adrenoceptor-blocking drugs, growth hormone and acromegaly.Postgrad Med J1980https://conductscience.org/library/papers/7433322PubMed
7286043Serum lipoprotein changes during atenolol treatment of essential hypertension.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7286043PubMed
7104159Effect of pindolol on serum lipids and lipid metabolizing enzymes.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7104159PubMed
7104158Antihypertensive drugs and blood lipids: the Oslo study.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7104158PubMed
7093112The short term effects of propranolol, atenolol and labetalol on antipyrine kinetics in normal subjects.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7093112PubMed
7037030Oxprenolol, methyldopa and lipids in diabetes mellitus.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7037030PubMed
6992822Atenolol v placebo in mild hypertension: renal metabolic and stress antipressor effects.Br J Clin Pharmacol1980https://conductscience.org/library/papers/6992822PubMed
6734694Effect of oxprenolol and metoprolol on serum lipid concentration.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6734694PubMed
6712860Changes in blood chemistry in hypertensive patients during propranolol therapy.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6712860PubMed
6661351Increased platelet adhesion and aggregation in hypertensive patients: effect of atenolol.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6661351PubMed
6145480Beta adrenoceptor blockade and responses of serum lipids to a meal and to exercise.Br Med J (Clin Res Ed)1984https://conductscience.org/library/papers/6145480PubMed
6144502Effects of antihypertensive drugs on endocrine function.Drugs1984https://conductscience.org/library/papers/6144502PubMed
6143851[Antihypertensive therapy and lipid metabolism].Klin Wochenschr1984https://conductscience.org/library/papers/6143851PubMed
6143667Effect of beta-blocking drugs on beta-cell function and insulin sensitivity in hypertensive non-diabetic patients.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6143667PubMed
6141317[Blood pressure during isometric and dynamic exercise under long-term antihypertensive treatment with beta receptor blockaders and diuretics].Klin Wochenschr1983https://conductscience.org/library/papers/6141317PubMed
6137813Thiazides, beta blockers and lipoproteins.Postgrad Med J1983https://conductscience.org/library/papers/6137813PubMed
6132652Which beta blocker?Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6132652PubMed
6127218Effects of a new long-acting beta-blocker bopindolol (LT 31-200) on blood pressure, plasma catecholamines, renin and cholesterol in patients with arterial hypertension.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/6127218PubMed

See all 40 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GCG2641PubTator's text mininghttps://conductscience.org/library/genes/2641NCBI Gene
GH12688PubTator's text mininghttps://conductscience.org/library/genes/2688NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/761001

GET https://conductscience.org/api/papers/v1/761001/cited_by?page=2